Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma

NCT05777707 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Carcinoma
Neoadjuvant Immunotherapy

Interventions

DRUG: PD-1 blockade
DRUG: Albumin paclitaxel
DRUG: Carboplatin/Nedaplatin

Sponsor

Beijing Friendship Hospital